
PentaBiol
Innovative postbiotic solutions enhancing animal health and productivity while reducing antibiotic use.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Seed | |
Total Funding | 000k |
EUR | 2019 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
% profit margin | (1 %) |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Company filings or news article
Related Content
Pentabiol operates in the animal feed industry, focusing on developing natural postbiotic technology to improve animal health and productivity. The company serves a diverse range of clients, including farmers and animal husbandry professionals, who are looking to enhance the health and performance of their livestock without relying on antibiotics. Pentabiol's market is primarily within the agricultural and food production sectors, where there is a growing demand for sustainable and health-conscious animal feed solutions.
The business model of Pentabiol revolves around research and innovation, creating a wide range of products tailored to different phases of animal development. These products are designed to improve the animals' response to diseases such as Salmonella and E. Coli, thereby reducing the need for antibiotics. Pentabiol generates revenue by selling these specialized feed products to its clients, who benefit from healthier animals and better productive performance.
Pentabiol's commitment to quality and traceability ensures that their products meet stringent food sector regulations, which are increasingly prohibiting harmful components like antibiotics. By focusing on natural solutions, Pentabiol not only promotes better animal health but also contributes to safer food for human consumption.
Keywords: postbiotic technology, animal health, productivity, antibiotic reduction, sustainable feed, research, innovation, livestock, disease response, food safety.